Creative Bioarray Releases in Vivo & in Vitro Toxicology to Accelerate Preclinical Research and Drug Development

DDA platform offers in vivo & in vitro toxicology services designed to accelerate preclinical research and drug development.

DDA platform, the division of Creative Bioarray, an innovative biotechnology company focuses on facilitating the investigation of life science researches, offers in vivo & in vitro toxicology services designed to accelerate preclinical research and drug development.

At Creative Bioarray, in vivo toxicology services range from acute (single dose) to chronic (multi-dose) dosing regimens. Several exposure routes are available in various species such as rodents, rabbits and guinea pigs (for example, oral, intravenous, intraperitoneal, intramuscular, topical, etc.). A comprehensive toxicology assessment can be obtained through internal resources or through strategic partnerships with external suppliers. These assessments include hematology, urinalysis, clinical chemistry, histopathology, biological analysis and toxicokinetics.

Because Creative Bioarray has advanced facilities and rich preclinical research experience, its skills and expertise can accelerate the development of drug candidates, from discovery to regulatory submission. Creative Bioarray provides sophisticated and unique evaluation methods, including ultrasound, CT scan, digital radiography, MRI, laser Doppler, IVIS imaging and contour photography. In addition, Creative Bioarray provides immunohistochemistry, ELISA, PCR, qPCR and immunogenicity testing, and has extensive experience in designing, implementing, evaluating and interpreting research results covering a wide range of endpoints, which means that data can be efficiently obtained in the format required by the customers.

In addition, Creative Bioarray is professional in utilizing primary cells from many different tissues and organs for predictive 3D tissue and cell-based in vitro toxicity assays. Knowing that saving time and cost control are valuable to customers, experienced scientists will work closely with customers and follow the best strategy to provide guidance, and which tests should be prioritized at different stages of the discovery process in order to maximize the chance of success.

The services offered by Creative Bioarray include but are not limited to: Cytotoxicity, Cardiotoxicity, Hepatotoxicity, Nephrotoxicity, Genotoxicity, Phototoxicity.

The advantages of Creative Bioarray Toxicology Services include:

Agreement formulation and regulatory guidance
Rodent and non-rodent models can be used for preclinical trials
Pharmacokinetics (PK) and toxicokinetics (TK), providing multiple routes of administration in multiple species
Advanced surgical research facilities
Competitive price
Fast turnaround time

“Creative Bioarray is the ideal partner to help you use another set of techniques to understand the toxicity of compounds. We can help you determine which compounds have the best safety and can enter the clinic. We focus on the most advanced technology and automation to generate high-quality data quickly and cost-effectively.” said Hannah Cole, the marketing director of Creative Bioarray, she also added, “We can perform customized solutions in order to satisfy specific needs of our customers with in-house experts and comprehensive platform.”

About DDA platform
As a mature division of Creative Bioarray, DDA platform definitely will be the ideal and reliable innovation partner in research endeavors. With the support of professional scientists and years of experience, We are capable to provide a knowledgeable, collaborative and flexible service to our clients so as to accelerated drug development and improved research quality for worldwide projects.

Contact Info:
Name: Hannah Cole
Email: Send Email
Organization: Creative Bioarray
Address: 45-1 Ramsey Road, Shirley, NY 11967, USA
Phone: 6316197922
Website: https://dda.creative-bioarray.com/

Release ID: 88975880